Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Stoke Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 396K | May 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
STOK | Stoke Therapeutics, Inc. | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Chief Financial Officer |
STOK | Stoke Therapeutics, Inc. | May 7, 2024 | 0 | $0 | 3 | May 17, 2024 | Chief Financial Officer |